For more information or confidential assistance
Call 800-306-3180

Plaintiffs Demand $2 Billion from Takeda in Actos Trial

A Las Vegas jury has begun hearing arguments regarding potential safety problems linked to Actos, a medication designed and manufactured by Takeda Pharmaceuticals. The Actos trial began on August 27th, 2015 before Judge Jerry Wiese in the Las Vegas District Court. During this high stakes... Read More

Arizona Plaintiffs File Joint Actos Lawsuit

Actos Prescription Drug
A number of plaintiffs from Tucson, AZ have filed a joint Actos lawsuit against Takeda Pharmaceuticals. Their lawsuit will join thousands currently pending under multidistrict litigation in the U.S. District Court for the Western District of Louisiana. Garry and Ruth Buchman are among the group... Read More

Takeda Reaches $2.4 Billion Actos Settlement

Takeda Pharmaceuticals has agreed to a $2.4 billion Actos settlement that would largely resolve thousands of claims regarding the drug’s risk of bladder cancer. The company said that the settlement would go into effect if at least 95% of current plaintiffs accept it; in this... Read More

FDA Advisory Panel: Onglyza Could Raise Heart Failure Risk

Periodically, the U.S. Food and Drug Administration (FDA) requests reviews of medications to determine if they present a potential safety risk. Diabetes medications in particular have proven problematic because of potential complications. These include a possible risk of bladder cancer for those taking Actos, and... Read More

Takeda Offers $2.2 Billion Actos Settlement

Actos
Takeda Pharmaceuticals, manufacturer of Actos, is willing to pay $2.2 billion to resolve claims that it concealed cancer risks linked to its diabetes medicine. The proposed Actos settlement, if accepted by plaintiffs, would mark one of the largest U.S. accords of patient lawsuits involving pharmaceutical... Read More

Actos Bladder Cancer Lawsuit Filed by 17 Plaintiffs

Actos lawsuit news
Seventeen plaintiffs have filed an Actos bladder cancer lawsuit against manufacturer Takeda Pharmaceuticals, claiming use of the type 2 diabetes treatment led to the diagnosis of bladder cancer. Four of the plaintiffs filed their complaint on behalf of family members that died after their bladder... Read More